These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3926922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Manipulating the follicular phase in IVF cycles: a comparison of two hMG stimulation protocols.
    Rabinowitz R, Simon A, Lewin A, Bar-Hava I, Schenker JG, Laufer N.
    Gynecol Endocrinol; 1989 Jun; 3(2):117-23. PubMed ID: 2510460
    [Abstract] [Full Text] [Related]

  • 5. Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles.
    Forman RG, Robinson J, Egan D, Ross C, Gosden B, Barlow DH.
    Fertil Steril; 1991 Mar; 55(3):567-73. PubMed ID: 1900482
    [Abstract] [Full Text] [Related]

  • 6. Simplification of the method of in vitro fertilization: sonographic measurements of follicular diameter as the sole index of follicular maturity.
    Nilsson L, Wikland M, Hamberger L, Hillensjö T, Chari S, Sturm G, Daume E.
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):17-22. PubMed ID: 3926921
    [Abstract] [Full Text] [Related]

  • 7. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).
    Kagawa T, Yamano S, Nishida S, Murayama S, Aono T.
    J Assist Reprod Genet; 1992 Apr; 9(2):106-12. PubMed ID: 1627924
    [Abstract] [Full Text] [Related]

  • 8. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE, Padilla SL, Bayati J, Baramki TA.
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [Abstract] [Full Text] [Related]

  • 9. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S, Kuang Y.
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R, Conway GS, Engmann L, Bekir JS, Jacobs HS.
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [Abstract] [Full Text] [Related]

  • 12. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.
    Garcia JE, Jones GS, Acosta AA, Wright G.
    Fertil Steril; 1983 Feb; 39(2):174-9. PubMed ID: 6401635
    [Abstract] [Full Text] [Related]

  • 13. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function.
    Polan ML, Daniele A, Russell JB, DeCherney AH.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1284-91. PubMed ID: 3097055
    [Abstract] [Full Text] [Related]

  • 14. Timing of hCG administration in cycles stimulated for in vitro fertilization: specific impact of heterogeneous follicle sizes and steroid concentrations in plasma and follicle fluid on decision procedures.
    Inaudi P, Germond M, Senn A, De Grandi P.
    Gynecol Endocrinol; 1995 Sep; 9(3):201-8. PubMed ID: 8540289
    [Abstract] [Full Text] [Related]

  • 15. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC, Jackson KV, Hornstein MD, Ginsburg ES.
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [Abstract] [Full Text] [Related]

  • 16. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.
    Ben-Rafael Z, Benadiva CA, Ausmanas M, Barber B, Blasco L, Flickinger GL, Mastroianni L.
    Fertil Steril; 1987 Dec; 48(6):964-8. PubMed ID: 3119377
    [Abstract] [Full Text] [Related]

  • 17. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z, Lang N, Amit A, Kahana L, Yoffe N.
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
    Pados G, Tarlatzis BC, Bontis J, Lagos S, Papadimas J, Spanos E, Mantalenakis S.
    Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
    [Abstract] [Full Text] [Related]

  • 19. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS, Shamma FN, Gutmann JN, Seifer DB, DeCherney AH, Lavy G.
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [Abstract] [Full Text] [Related]

  • 20. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981.
    Garcia JE, Jones GS, Acosta AA, Wright G.
    Fertil Steril; 1983 Feb; 39(2):167-73. PubMed ID: 6217993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.